About Us

TICEBA is a highly innovative German bio-pharmaceutical company acting in the field of stem cell research and regenerative medicine.

TICEBA - Company - Picture 01TICEBA - Company - Picture 02

 

TICEBA conducts the sampling and long term storage of stem cells from the human skin based on its own research. International research findings are taken into account and the highest international standards are met.

TICEBA is the first tissue bank worldwide to offer its customers the personal and individual storage of skin tissue and the stem cells contained therein - as unique, valuable health care measure at the highest level and in accordance with the latest findings of science and technology.

News
Clinical Trials

We are now also recruiting patients for further clinical studies in phase I/IIa with allogeneic ABCB5-positive (ABCB5+) mesenchymal stem cells for the following indications: chronic venous ulcer (CVU), diabetic foot ulcer (DFU) and peripheral arterial occlusive disease (PAOD). For more information click HERE.

License

Besides the authorization to manufacture a human medicinal product in accordance with § 13 (1) of the German Medicinal Products Act (AMG) for autologous mesenchymal stem cells, TICEBA is also authorized to manufacture a medicinal product for allogeneic mesenchymal as well as allogeneic limbal ABCB5 + stem cells following a recent extension. For more information click HERE.

The Story of Stem Cells

Review our category "The Story of Stem Cells" with the newest topic "Stem cells in wound healing" HERE.

Newsletter